Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-5
Closed -$1.42K 93
2024
Q1
$1.42K Hold
5
﹤0.01% 133
2023
Q4
$1.44K Sell
5
-150
-97% -$40.9K ﹤0.01% 158
2023
Q3
$34.4K Hold
155
0.01% 110
2023
Q2
$34.4K Hold
155
0.01% 99
2023
Q1
$37.5K Buy
155
+152
+5,067% +$37.3K 0.01% 74
2022
Q4
$419 Buy
+3
New +$804 ﹤0.01% 507
2022
Q3
Sell
-37
Closed -$9K 158
2022
Q2
$9K Buy
+37
New +$9.07K ﹤0.01% 133
2021
Q3
Sell
-35
Closed -$8K 144
2021
Q2
$8K Buy
+35
New +$8.61K ﹤0.01% 72
2020
Q3
Sell
-30
Closed -$7K 152
2020
Q2
$7K Buy
+30
New +$6.84K ﹤0.01% 104

Other funds holding AMGN

TFO Wealth Partners's AMGN Position: Q2 2024 in Review

TFO Wealth Partners sold out of Amgen (AMGN) in Q2 2024, closing a stake of 5 shares — an estimated $1.42K sold.

TFO Wealth Partners first reported a position in AMGN in Q2 2020 and held it in 9 quarters. The position peaked at $37.5K in Q1 2023. 2,784 funds tracked by Wall St. Rank hold AMGN as of Q2 2024.

  • TFO Wealth Partners reported no remaining Amgen position as of Q2 2024 after selling out during the quarter.
  • TFO Wealth Partners sold 5 Amgen shares in Q2 2024, an estimated $1.42K.
  • TFO Wealth Partners first reported a position in Amgen in Q2 2020 and held it in 9 quarters.
  • TFO Wealth Partners's Amgen position peaked at $37.5K in Q1 2023.
  • 2,784 funds tracked by Wall St. Rank held Amgen as of Q2 2024.

Based on TFO Wealth Partners's 13F filing for Q2 2024, filed 15 Aug 2024.